GlassScriptPhysician profile
James D Griffin
NPI 1801858683
$744.61
in general payments reported to CMS, 2019-2025
10 companies · $133 in 2025
The $133 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.52 · 2020: $92.32 · 2022: $16.66 · 2023: $72.36 · 2024: $379 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.96 | 2024 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $117.85 | 2024 | |
| Atricure, INC. | $112.60 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Masimo Corporation | $92.32 | 2020 | |
| Edwards Lifesciences Corporation | $79.67 | 2022-2024 | Hemosphere |
| Sage Therapeutics, LLC | $72.36 | 2023 | |
| Pfizer INC. | $51.52 | 2019 | |
| Becton, Dickinson and Company | $40.82 | 2024 | Hemosphere |
| Ambu INC. | $35.58 | 2024 | |
| Solventum Corporation | $19.93 | 2025 | Bair Paws |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.